Joshua Pinto
Chief Financial Officer, Neumora Therapeutics, Inc.
Companies
- Neumora Therapeutics, Inc.Board member Aug 21, 2026 to now1
- Neumora Therapeutics, Inc.Chief executive officer Aug 21, 2026 to now1
- Neumora Therapeutics, Inc.President Feb 18, 2025 to now2
- Metsera, Inc.Board member Jan 30, 2025 to now3
- Neumora Therapeutics, Inc.Chief financial officer Sep 14, 2023 to Aug 27, 20244
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Neumora Therapeutics, Inc. NMRA209,950 shares5$99.3K at $0.47Feb 19, 2026
- Metsera, Inc.0 shares6Nov 13, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 17, 2026Sold 5,967 shares at $3.54 of Neumora Therapeutics, Inc.5
- Nov 13, 2025Returned to company 2,688 shares of Metsera, Inc.6
- May 21, 2025Gift 13,202 shares of Neumora Therapeutics, Inc.7
- May 21, 2025Gift 13,202 shares of Neumora Therapeutics, Inc.7
- Feb 18, 2025Sold 8,048 shares at $1.67 of Neumora Therapeutics, Inc.8
- Aug 27, 2024Sold 15,693 shares at $11.39 of Neumora Therapeutics, Inc.9
- Aug 26, 2024Sold 31,642 shares at $11.78 of Neumora Therapeutics, Inc.10
- Aug 23, 2024Sold 24,169 shares at $11.59 of Neumora Therapeutics, Inc.10
- Aug 22, 2024Sold 28,496 shares at $11.63 of Neumora Therapeutics, Inc.10
- Apr 17, 2024Gift 238,965 shares of Neumora Therapeutics, Inc.11
- Feb 14, 2024Granted 85,000 shares of Neumora Therapeutics, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARMetsera, Inc., Board member
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed May 23, 2025
- 8SEC EDGARForm 4 filed Feb 20, 2025
- 9SEC EDGARForm 4 filed Aug 27, 2024
- 10SEC EDGARForm 4 filed Aug 26, 2024
- 11SEC EDGARForm 4 filed Jun 28, 2024
- 12SEC EDGARForm 4 filed Feb 16, 2024